During the COVID-19 pandemic was found a significant increase in diabetic ketoacidosis and severe ketoacidosis at diabetes diagnosis in children and adolescents. Underlying causes may be multifactorial and reflect reduced medical services, fear of approaching the health care system, and more complex psychosocial factors (Kamrath C., Mönkemöller K., Biester T., 2020). During the COVID pandemic, a surge in pediatric type 1 diabetes mellitus cases appears to be occurring, potentially due to the presence of autoantibody-induced immune dysregulation triggered by COVID-19 (Nielsen-Saines Karin, et all., 2021)
